SecBot SecBot
SECBOTREPLAY Home › Report › TNGX

TNGX · Director Daniella Beckman filed a Form 144 notice of intent to sell…

Tango Therapeutics, Inc. · 144 filed Jun 10, 2026 at 16:45 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 10, 2026 at 16:45 ET

Director Daniella Beckman filed a Form 144 notice of intent to sell 4,446 shares of Tango Therapeutics common stock, with an approximate market value of $133,380 based on a $30.00 reference price. The shares being sold amount to less than 0.01% of the company's $4.6B market cap and represent stock acquired through option exercise and restricted stock vesting. This is a routine and immaterial insider sale by a director, consistent with compensation-related share liquidation.

  • Director Daniella Beckman filed Form 144 to sell 4,446 shares of Tango Therapeutics
  • Approximate market value of proposed sale: $133,380
  • Shares acquired via stock option exercise (914 shares) and restricted stock vesting (3,532 shares from 2017 grants)
  • Sale represents ~0.003% of $4.6B market cap, immaterial dilution concern

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access